Type II Diabetes
Conditions
Brief summary
The aim of this study and the primary outcome is to clinically evaluate effect of laparoscopic duodenal-jejunal bypass on non-obese type 2 diabetes. Secondary outcomes will evaluate CCK, FFA, Cholesterol Ghrelin, C-peptide, and HbA1c levels. Patients will be followed closely to ensure the desired results are sustained in long term
Interventions
None listed
Sponsors
Ferzli, George S., M.D. F.A.C.S.
Study design
Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* Adults age 20-65 years * Clinical diagnosis of type II diabetes buy on of the following three criteria (American Diabetes Association) 1. A normal or high C-peptide level (to exclude type 1 diabetes) (\>.9ng/ml) 2. A random plasma glucose of 200mg/dl or more with typical symptom of diabetes 3. A fasting plasma glucose of 126mg/dl or more on more than one occasion * BMI 22-34 KG/m2 * Patients on oral hypoglycemic medications or insulin to control T2DM * Inadequate control of diabetes as defined as HbA1c\>7.5 * No contraindication for surgery or General Anesthesia as determined by multidisciplinary surgical team * Ability to understand and describe the mechanism of action of ricks and benefits of the operation
Exclusion criteria
* Patients who meet any of the following
Countries
United States
Contacts
Primary ContactGeorge Ferzli, MD
Outcome results
None listed